SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY ARTICLE M impact

Daito Pharmaceutical Reports First-Quarter Net Profit

For the quarter ended August 31, 2026, revenue, operating profit, pretax profit and net profit were reported. Net profit was higher than the prior-year figure; the source also reports lower revenue and operating profit year over year.

4577

Daito Pharmaceutical Co. Ltd. 01 bln in 2025. 05 bln.

00 mln. The quarter ended August 31, 2026.